These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 17012701

  • 1. Ethical concerns regarding olanzapine versus placebo in patients prodromally symptomatic for psychosis.
    Block JJ.
    Am J Psychiatry; 2006 Oct; 163(10):1838; author reply 1838. PubMed ID: 17012701
    [No Abstract] [Full Text] [Related]

  • 2. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis.
    McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, Hawkins KA, Hoffman RE, Preda A, Epstein I, Addington D, Lindborg S, Trzaskoma Q, Tohen M, Breier A.
    Am J Psychiatry; 2006 May; 163(5):790-9. PubMed ID: 16648318
    [Abstract] [Full Text] [Related]

  • 3. Olanzapine and pediatric bipolar disorder: evidence for efficacy and safety concerns.
    McClellan JM.
    Am J Psychiatry; 2007 Oct; 164(10):1462-4. PubMed ID: 17898331
    [No Abstract] [Full Text] [Related]

  • 4. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
    Ascher-Svanum H, Stensland M, Zhao Z, Kinon BJ.
    BMC Psychiatry; 2005 Jan 13; 5():3. PubMed ID: 15649317
    [Abstract] [Full Text] [Related]

  • 5. Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: a 12-week double-blind, placebo-controlled pilot study.
    Baptista T, Uzcátegui E, Rangel N, El Fakih Y, Galeazzi T, Beaulieu S, de Baptista EA.
    Psychiatry Res; 2008 May 30; 159(1-2):250-3. PubMed ID: 18374423
    [Abstract] [Full Text] [Related]

  • 6. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
    McQuade RD, Stock E, Marcus R, Jody D, Gharbia NA, Vanveggel S, Archibald D, Carson WH.
    J Clin Psychiatry; 2004 May 30; 65 Suppl 18():47-56. PubMed ID: 15600384
    [Abstract] [Full Text] [Related]

  • 7. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
    Wu RR, Zhao JP, Guo XF, He YQ, Fang MS, Guo WB, Chen JD, Li LH.
    Am J Psychiatry; 2008 Mar 30; 165(3):352-8. PubMed ID: 18245179
    [Abstract] [Full Text] [Related]

  • 8. A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain.
    Henderson DC, Copeland PM, Daley TB, Borba CP, Cather C, Nguyen DD, Louie PM, Evins AE, Freudenreich O, Hayden D, Goff DC.
    Am J Psychiatry; 2005 May 30; 162(5):954-62. PubMed ID: 15863798
    [Abstract] [Full Text] [Related]

  • 9. Olanzapine versus placebo in the treatment of adolescents with bipolar mania.
    Tohen M, Kryzhanovskaya L, Carlson G, Delbello M, Wozniak J, Kowatch R, Wagner K, Findling R, Lin D, Robertson-Plouch C, Xu W, Dittmann RW, Biederman J.
    Am J Psychiatry; 2007 Oct 30; 164(10):1547-56. PubMed ID: 17898346
    [Abstract] [Full Text] [Related]

  • 10. Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients.
    Chen CH, Huang MC, Lu ML.
    J Clin Psychopharmacol; 2007 Oct 30; 27(5):516-7. PubMed ID: 17873689
    [No Abstract] [Full Text] [Related]

  • 11. Olanzapine and weight gain.
    Isaac MB, Isaac MT.
    Am J Psychiatry; 2005 Sep 30; 162(9):1764-5; author reply 1765. PubMed ID: 16135655
    [No Abstract] [Full Text] [Related]

  • 12. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.
    Tohen M, Calabrese JR, Sachs GS, Banov MD, Detke HC, Risser R, Baker RW, Chou JC, Bowden CL.
    Am J Psychiatry; 2006 Feb 30; 163(2):247-56. PubMed ID: 16449478
    [Abstract] [Full Text] [Related]

  • 13. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S, Ameen S, Akhtar S.
    J Clin Psychopharmacol; 2008 Feb 30; 28(1):27-31. PubMed ID: 18204337
    [Abstract] [Full Text] [Related]

  • 14. Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychotic.
    Ascher-Svanum H, Stensland MD, Kinon BJ, Tollefson GD.
    J Psychopharmacol; 2005 Nov 30; 19(6 Suppl):110-7. PubMed ID: 16280344
    [Abstract] [Full Text] [Related]

  • 15. Methodological concerns in a trial of ziprasidone and olanzapine.
    Carnahan RM, Perry PJ.
    Am J Psychiatry; 2005 Jul 30; 162(7):1391; author reply 1391-2. PubMed ID: 15994736
    [No Abstract] [Full Text] [Related]

  • 16. Six-month, blinded, multicenter continuation study of ziprasidone versus olanzapine in schizophrenia.
    Simpson GM, Weiden P, Pigott T, Murray S, Siu CO, Romano SJ.
    Am J Psychiatry; 2005 Aug 30; 162(8):1535-8. PubMed ID: 16055779
    [Abstract] [Full Text] [Related]

  • 17. Olanzapine treatment of eight adolescent patients with psychosis.
    Ercan ES, Kutlu A, Varan A, Cikoğlu S, Coşkunol H, Bayraktar E.
    Hum Psychopharmacol; 2004 Jan 30; 19(1):53-6. PubMed ID: 14716713
    [Abstract] [Full Text] [Related]

  • 18. Newer antipsychotic drugs and obesity in children and adolescents. How should we assess drug-associated weight gain?
    Vieweg WV, Sood AB, Pandurangi A, Silverman JJ.
    Acta Psychiatr Scand; 2005 Mar 30; 111(3):177-84. PubMed ID: 15701101
    [Abstract] [Full Text] [Related]

  • 19. Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: a randomized, double-blind placebo controlled trial.
    Strous RD, Stryjer R, Maayan R, Gal G, Viglin D, Katz E, Eisner D, Weizman A.
    Psychoneuroendocrinology; 2007 Feb 30; 32(2):96-105. PubMed ID: 17208382
    [Abstract] [Full Text] [Related]

  • 20. Safety of olanzapine.
    Beasley CM, Tollefson GD, Tran PV.
    J Clin Psychiatry; 1997 Feb 30; 58 Suppl 10():13-7. PubMed ID: 9265911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.